Rhythm

Results of Landmark Wearable Defibrillator Trial to Be Presented as ACC.18 Late-Breaker

CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that findings from the “Vest Prevention of Early Sudden Death Trial” (VEST Trial) on use of the ZOLL LifeVest® wearable cardioverter defibrillator (WCD) will be presented as a Late-Breaking Clinical Trial at the American […]

CardioFocus Announces Intiation of HeartLight® X3 Clinical Evaluation

MARLBOROUGH, Mass., Feb. 26, 2018 /PRNewswire/ — CardioFocus, Inc., a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF), today announced the initiation of a clinical evaluation of the new HeartLight X3 System for the treatment of AF. Building upon the advanced features of the […]

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center to host EPLive 2018

AUSTIN, Texas, Feb. 26, 2018 /PRNewswire/ — On March 1 and 2, 2018, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center will host its fourth international symposium on complex arrhythmias, EPLive 2018. EPLive is an intensive, two-day educational meeting for practicing clinical cardiac electrophysiologists, electrophysiologist fellows and […]

Cardiva Medical Brings Total Financing Round to $41 Million; Announces Sponsorship of AMBULATE Trial, First Vascular Closure Trial Targeted at High Growth Electrophysiology Procedures

New Vascular Closure Device for Multi-Access Mid-Bore Vein Procedures, Specifically Cardiac Ablation, Aims to Reduce Time to Ambulation and Improve the Patient Experience SANTA CLARA, Calif.–(BUSINESS WIRE)– Cardiva Medical ®, an innovator in the field of vascular closure, today announced that the company has closed on $11 million in additional financing – […]

CRM Devices Market Size Worth $32.4 Billion By 2025 | CAGR: 7.8%: Grand View Research, Inc.

SAN FRANCISCO, February 19, 2018 /PRNewswire/ — The global cardiac rhythm management (CRM) devices market size is anticipated to reach USD 32.4 billion by 2025, according to a new report by Grand View Research, Inc., registering a 7.8% CAGR during the forecast period. Increase in demand for CRM devices can be attributed to supportive legislative policies […]

Cardiac Insight, Inc. Welcomes Renowned Atrial Fibrillation Cardiologists Professor John Camm and Albert L. Waldo, MD to its Scientific Advisory Board

KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading U.S. developer of wearable medical devices and diagnostic software, announced today the company continues to garner global interest in its approach to cardiac care, and has added renowned cardiologists and atrial fibrillation (AFib) specialists, Professor John Camm and Albert L. Waldo, MD, PhD […]

Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women’s Initiative for Heart Recovery

DANVERS, Mass., Feb. 13, 2018 (GLOBE NEWSWIRE) — Abiomed(NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the launch of a new indication and Women’s Initiative focused on heart recovery education and awareness. This Women’s Initiative is in conjunction with the Company’s expanded FDA approval for cardiogenic […]

American College of Cardiology Expands Patient Navigator Program

WASHINGTON, Feb. 8, 2018 /PRNewswire-USNewswire/ — Hundreds of hospitals across the United States will have access to tools and resources to help improve care and lower readmission rates for myocardial infarction (MI) patients as part of the American College of Cardiology’s expanded Patient Navigator Program: Focus MI Quality Campaign. With support from founding sponsor AstraZeneca, […]

ClearFlow Release: Studies Recognizing the Importance of Limiting Retained Blood to Prevent Postoperative Atrial Fibrillation Featured on January Cover of Annals of Thoracic Surgery

Feb. 1, 2018 19:16 UTC –ClearFlow spokespeople cite review article as latest piece of mounting evidence pertaining to urgent need for managing retained blood after surgery– ANAHEIM, Calif.–(BUSINESS WIRE)– ClearFlow, a medical device company based in Anaheim, CA., has announced that the cover of the January 2018 issue of The Annals of […]

HeartSciences Showcases High Sensitivity ECG at 2018 Arab Health Meeting

SOUTHLAKE, Texas–(BUSINESS WIRE)– HeartSciences, an innovative medical device company, is proud to announce its participation as an exhibitor at the upcoming 2018 Arab Health show at the Dubai International Convention and Exhibition Centre in Dubai, UAE, 29 January through 01 February, 2018. HeartSciences is advancing the field of electrocardiology in combining […]